Anumana, Pfizer collaborate on AI-based detection of cardiovascular disease

Related Articles
Anumana Named to Fast Company’s 2024 Next Big Things in Tech Awards
Award recognizes Anumana’s innovative AI-driven cardiovascular disease detection technologyNovember 19, 2024
Mayo Clinic launches two new companies
DotMed: Mayo Clinic has launched two new companies to support its new technology initiative, the Remote Diagnostics and Management Platform. The solution applies artificial intelligence to derive insights from data…April 18, 2021
Pfizer and Anumana boost detection of cardiovascular disease
Pharma Times: Artificial intelligence (AI) health technology company, Anumana, will collaborate with Pfizer to develop an artificial intelligence electrocardiogram algorithm (AI-ECG), which enables the early detection of cardiac amyloidosis.December 16, 2022
StartUp Health Insights: Virta & 1Doc3 Close Rounds, Over $1.4B Raised This Week
Health Transformer: Anumana, a startup designing neural network algorithms to enable early detection and accelerate treatment of heart disease, raised $25.7M led by founders nference and Mayo Clinic, with participation…April 20, 2021


